Crispr Therapeutics AG (CRSP)
NASDAQ · Healthcare
Crispr Therapeutics AG Cash on Hand 2015–2025
Crispr Therapeutics AG annual/quarterly cash on hand history from 2015 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Crispr Therapeutics AG cash on hand for the quarter ending December 31, 2025 were 347.6M, a 16.53% increase year-over-year.
- Crispr Therapeutics AG cash on hand for 2025 were 347.6M, a 16.53% increase from 2024.
- Crispr Therapeutics AG cash on hand for 2024 were 298.3M, a 23.42% decrease from 2023.
- Crispr Therapeutics AG cash on hand for 2023 were 389.5M, a 83.82% increase from 2022.
- Crispr Therapeutics AG cash on hand for 2022 were 211.9M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Crispr Therapeutics AG Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $348 |
| 2024 | $298 |
| 2023 | $389 |
| 2022 | $212 |
| 2021 | $923 |
| 2020 | $1,169 |
| 2019 | $944 |
| 2018 | $457 |
| 2017 | $240 |
| 2016 | $316 |
| 2015 | $156 |
| Crispr Therapeutics AG Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $348 |
| 2024-12-31 | $298 |
| 2023-12-31 | $389 |
| 2022-12-31 | $212 |
| 2021-12-31 | $923 |
| 2020-12-31 | $1,169 |
| 2019-12-31 | $944 |
| 2018-12-31 | $457 |
| 2017-12-31 | $240 |
| 2016-12-31 | $316 |
| 2015-12-31 | $156 |
Crispr Therapeutics AG Cash on Hand — FAQ
Crispr Therapeutics AG (CRSP) cash on hand over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRSP's cash on hand history?
The chart and table above show Crispr Therapeutics AG's cash on hand by year and by quarter, including the growth rate.